Opioid Induced Constipation Drugs Market - Global Outlook and Forecast 2021-2027

Opioid Induced Constipation Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Opioid Induced Constipation Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Induced Constipation Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid Induced Constipation Drugs Overall Market Size
2.1 Global Opioid Induced Constipation Drugs Market Size: 2021 VS 2027
2.2 Global Opioid Induced Constipation Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Opioid Induced Constipation Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Opioid Induced Constipation Drugs Players in Global Market
3.2 Top Global Opioid Induced Constipation Drugs Companies Ranked by Revenue
3.3 Global Opioid Induced Constipation Drugs Revenue by Companies
3.4 Global Opioid Induced Constipation Drugs Sales by Companies
3.5 Global Opioid Induced Constipation Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Opioid Induced Constipation Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Opioid Induced Constipation Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid Induced Constipation Drugs Players in Global Market
3.8.1 List of Global Tier 1 Opioid Induced Constipation Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid Induced Constipation Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioid Induced Constipation Drugs Market Size Markets, 2021 & 2027
4.1.2 Lubiprostone
4.1.3 Methyl Naltrexone Bromide
4.1.4 Naldemedine
4.1.5 Alvimopan
4.1.6 Others
4.2 By Type - Global Opioid Induced Constipation Drugs Revenue & Forecasts
4.2.1 By Type - Global Opioid Induced Constipation Drugs Revenue, 2016-2021
4.2.2 By Type - Global Opioid Induced Constipation Drugs Revenue, 2022-2027
4.2.3 By Type - Global Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Opioid Induced Constipation Drugs Sales & Forecasts
4.3.1 By Type - Global Opioid Induced Constipation Drugs Sales, 2016-2021
4.3.2 By Type - Global Opioid Induced Constipation Drugs Sales, 2022-2027
4.3.3 By Type - Global Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Opioid Induced Constipation Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Opioid Induced Constipation Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Opioid Induced Constipation Drugs Revenue & Forecasts
5.2.1 By Application - Global Opioid Induced Constipation Drugs Revenue, 2016-2021
5.2.2 By Application - Global Opioid Induced Constipation Drugs Revenue, 2022-2027
5.2.3 By Application - Global Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Opioid Induced Constipation Drugs Sales & Forecasts
5.3.1 By Application - Global Opioid Induced Constipation Drugs Sales, 2016-2021
5.3.2 By Application - Global Opioid Induced Constipation Drugs Sales, 2022-2027
5.3.3 By Application - Global Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Opioid Induced Constipation Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Opioid Induced Constipation Drugs Market Size, 2021 & 2027
6.2 By Region - Global Opioid Induced Constipation Drugs Revenue & Forecasts
6.2.1 By Region - Global Opioid Induced Constipation Drugs Revenue, 2016-2021
6.2.2 By Region - Global Opioid Induced Constipation Drugs Revenue, 2022-2027
6.2.3 By Region - Global Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Opioid Induced Constipation Drugs Sales & Forecasts
6.3.1 By Region - Global Opioid Induced Constipation Drugs Sales, 2016-2021
6.3.2 By Region - Global Opioid Induced Constipation Drugs Sales, 2022-2027
6.3.3 By Region - Global Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Opioid Induced Constipation Drugs Revenue, 2016-2027
6.4.2 By Country - North America Opioid Induced Constipation Drugs Sales, 2016-2027
6.4.3 US Opioid Induced Constipation Drugs Market Size, 2016-2027
6.4.4 Canada Opioid Induced Constipation Drugs Market Size, 2016-2027
6.4.5 Mexico Opioid Induced Constipation Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Opioid Induced Constipation Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Opioid Induced Constipation Drugs Sales, 2016-2027
6.5.3 Germany Opioid Induced Constipation Drugs Market Size, 2016-2027
6.5.4 France Opioid Induced Constipation Drugs Market Size, 2016-2027
6.5.5 U.K. Opioid Induced Constipation Drugs Market Size, 2016-2027
6.5.6 Italy Opioid Induced Constipation Drugs Market Size, 2016-2027
6.5.7 Russia Opioid Induced Constipation Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Opioid Induced Constipation Drugs Market Size, 2016-2027
6.5.9 Benelux Opioid Induced Constipation Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Opioid Induced Constipation Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Opioid Induced Constipation Drugs Sales, 2016-2027
6.6.3 China Opioid Induced Constipation Drugs Market Size, 2016-2027
6.6.4 Japan Opioid Induced Constipation Drugs Market Size, 2016-2027
6.6.5 South Korea Opioid Induced Constipation Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Opioid Induced Constipation Drugs Market Size, 2016-2027
6.6.7 India Opioid Induced Constipation Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Opioid Induced Constipation Drugs Revenue, 2016-2027
6.7.2 By Country - South America Opioid Induced Constipation Drugs Sales, 2016-2027
6.7.3 Brazil Opioid Induced Constipation Drugs Market Size, 2016-2027
6.7.4 Argentina Opioid Induced Constipation Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales, 2016-2027
6.8.3 Turkey Opioid Induced Constipation Drugs Market Size, 2016-2027
6.8.4 Israel Opioid Induced Constipation Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Opioid Induced Constipation Drugs Market Size, 2016-2027
6.8.6 UAE Opioid Induced Constipation Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Ironwood Pharmaceuticals Inc
7.1.1 Ironwood Pharmaceuticals Inc Corporate Summary
7.1.2 Ironwood Pharmaceuticals Inc Business Overview
7.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Major Product Offerings
7.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Ironwood Pharmaceuticals Inc Key News
7.2 Daiichi Sankyo Co Ltd
7.2.1 Daiichi Sankyo Co Ltd Corporate Summary
7.2.2 Daiichi Sankyo Co Ltd Business Overview
7.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Daiichi Sankyo Co Ltd Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Opioid Induced Constipation Drugs Major Product Offerings
7.3.4 Pfizer Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 Progenics Pharmaceuticals Inc
7.4.1 Progenics Pharmaceuticals Inc Corporate Summary
7.4.2 Progenics Pharmaceuticals Inc Business Overview
7.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Major Product Offerings
7.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Progenics Pharmaceuticals Inc Key News
7.5 Shionogi & Co., Ltd
7.5.1 Shionogi & Co., Ltd Corporate Summary
7.5.2 Shionogi & Co., Ltd Business Overview
7.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.5.4 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Shionogi & Co., Ltd Key News
7.6 Allergan Plc
7.6.1 Allergan Plc Corporate Summary
7.6.2 Allergan Plc Business Overview
7.6.3 Allergan Plc Opioid Induced Constipation Drugs Major Product Offerings
7.6.4 Allergan Plc Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Allergan Plc Key News
7.7 Nektar Therapeutics
7.7.1 Nektar Therapeutics Corporate Summary
7.7.2 Nektar Therapeutics Business Overview
7.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Major Product Offerings
7.4.4 Nektar Therapeutics Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Nektar Therapeutics Key News
7.8 Purdue Pharma
7.8.1 Purdue Pharma Corporate Summary
7.8.2 Purdue Pharma Business Overview
7.8.3 Purdue Pharma Opioid Induced Constipation Drugs Major Product Offerings
7.8.4 Purdue Pharma Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Purdue Pharma Key News
7.9 S.L.A. Pharma AG
7.9.1 S.L.A. Pharma AG Corporate Summary
7.9.2 S.L.A. Pharma AG Business Overview
7.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Major Product Offerings
7.9.4 S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.9.5 S.L.A. Pharma AG Key News
7.10 Mundipharma International Limited
7.10.1 Mundipharma International Limited Corporate Summary
7.10.2 Mundipharma International Limited Business Overview
7.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Major Product Offerings
7.10.4 Mundipharma International Limited Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Mundipharma International Limited Key News
7.11 Ono Pharmaceutical Co., Ltd
7.11.1 Ono Pharmaceutical Co., Ltd Corporate Summary
7.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Business Overview
7.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Major Product Offerings
7.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Ono Pharmaceutical Co., Ltd Key News
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Major Product Offerings
7.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Takeda Pharmaceutical Company Limited Key News
7.13 Theravance Biopharma Inc
7.13.1 Theravance Biopharma Inc Corporate Summary
7.13.2 Theravance Biopharma Inc Opioid Induced Constipation Drugs Business Overview
7.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Major Product Offerings
7.13.4 Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Theravance Biopharma Inc Key News
7.14 Bausch Health
7.14.1 Bausch Health Corporate Summary
7.14.2 Bausch Health Business Overview
7.14.3 Bausch Health Opioid Induced Constipation Drugs Major Product Offerings
7.14.4 Bausch Health Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.14.5 Bausch Health Key News
7.15 Cosmo Pharmaceuticals SA
7.15.1 Cosmo Pharmaceuticals SA Corporate Summary
7.15.2 Cosmo Pharmaceuticals SA Business Overview
7.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Major Product Offerings
7.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.15.5 Cosmo Pharmaceuticals SA Key News
7.16 Daewoong Pharmaceutical
7.16.1 Daewoong Pharmaceutical Corporate Summary
7.16.2 Daewoong Pharmaceutical Business Overview
7.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Major Product Offerings
7.16.4 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.16.5 Daewoong Pharmaceutical Key News
7.17 C.B. Fleet Company
7.17.1 C.B. Fleet Company Corporate Summary
7.17.2 C.B. Fleet Company Business Overview
7.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Major Product Offerings
7.17.4 C.B. Fleet Company Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.17.5 C.B. Fleet Company Key News
7.18 Sucampo Pharmaceuticals
7.18.1 Sucampo Pharmaceuticals Corporate Summary
7.18.2 Sucampo Pharmaceuticals Business Overview
7.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Major Product Offerings
7.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales and Revenue in Global (2016-2021)
7.18.5 Sucampo Pharmaceuticals Key News
8 Global Opioid Induced Constipation Drugs Production Capacity, Analysis
8.1 Global Opioid Induced Constipation Drugs Production Capacity, 2016-2027
8.2 Opioid Induced Constipation Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid Induced Constipation Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioid Induced Constipation Drugs Supply Chain Analysis
10.1 Opioid Induced Constipation Drugs Industry Value Chain
10.2 Opioid Induced Constipation Drugs Upstream Market
10.3 Opioid Induced Constipation Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid Induced Constipation Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Opioid Induced Constipation Drugs in Global Market
Table 2. Top Opioid Induced Constipation Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Opioid Induced Constipation Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Opioid Induced Constipation Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Opioid Induced Constipation Drugs Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Opioid Induced Constipation Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Opioid Induced Constipation Drugs Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Opioid Induced Constipation Drugs Product Type
Table 9. List of Global Tier 1 Opioid Induced Constipation Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Induced Constipation Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2016-2021
Table 15. By Type - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2022-2027
Table 16. By Application - Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2016-2021
Table 20. By Application - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2022-2027
Table 21. By Region - Global Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Opioid Induced Constipation Drugs Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2016-2021
Table 25. By Region - Global Opioid Induced Constipation Drugs Sales (K Pcs), 2022-2027
Table 26. By Country - North America Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Opioid Induced Constipation Drugs Sales, (K Pcs), 2016-2021
Table 29. By Country - North America Opioid Induced Constipation Drugs Sales, (K Pcs), 2022-2027
Table 30. By Country - Europe Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Opioid Induced Constipation Drugs Sales, (K Pcs), 2016-2021
Table 33. By Country - Europe Opioid Induced Constipation Drugs Sales, (K Pcs), 2022-2027
Table 34. By Region - Asia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Opioid Induced Constipation Drugs Sales, (K Pcs), 2016-2021
Table 37. By Region - Asia Opioid Induced Constipation Drugs Sales, (K Pcs), 2022-2027
Table 38. By Country - South America Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Opioid Induced Constipation Drugs Sales, (K Pcs), 2016-2021
Table 41. By Country - South America Opioid Induced Constipation Drugs Sales, (K Pcs), 2022-2027
Table 42. By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales, (K Pcs), 2016-2021
Table 45. By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales, (K Pcs), 2022-2027
Table 46. Ironwood Pharmaceuticals Inc Corporate Summary
Table 47. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Offerings
Table 48. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 49. Daiichi Sankyo Co Ltd Corporate Summary
Table 50. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product Offerings
Table 51. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Opioid Induced Constipation Drugs Product Offerings
Table 54. Pfizer Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 55. Progenics Pharmaceuticals Inc Corporate Summary
Table 56. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Offerings
Table 57. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 58. Shionogi & Co., Ltd Corporate Summary
Table 59. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product Offerings
Table 60. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 61. Allergan Plc Corporate Summary
Table 62. Allergan Plc Opioid Induced Constipation Drugs Product Offerings
Table 63. Allergan Plc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 64. Nektar Therapeutics Corporate Summary
Table 65. Nektar Therapeutics Opioid Induced Constipation Drugs Product Offerings
Table 66. Nektar Therapeutics Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 67. Purdue Pharma Corporate Summary
Table 68. Purdue Pharma Opioid Induced Constipation Drugs Product Offerings
Table 69. Purdue Pharma Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 70. S.L.A. Pharma AG Corporate Summary
Table 71. S.L.A. Pharma AG Opioid Induced Constipation Drugs Product Offerings
Table 72. S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 73. Mundipharma International Limited Corporate Summary
Table 74. Mundipharma International Limited Opioid Induced Constipation Drugs Product Offerings
Table 75. Mundipharma International Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 76. Ono Pharmaceutical Co., Ltd Corporate Summary
Table 77. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product Offerings
Table 78. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 79. Takeda Pharmaceutical Company Limited Corporate Summary
Table 80. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product Offerings
Table 81. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 82. Theravance Biopharma Inc Corporate Summary
Table 83. Theravance Biopharma Inc Opioid Induced Constipation Drugs Product Offerings
Table 84. Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 85. Bausch Health Corporate Summary
Table 86. Bausch Health Opioid Induced Constipation Drugs Product Offerings
Table 87. Bausch Health Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 88. Cosmo Pharmaceuticals SA Corporate Summary
Table 89. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product Offerings
Table 90. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 91. Daewoong Pharmaceutical Corporate Summary
Table 92. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product Offerings
Table 93. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 94. C.B. Fleet Company Corporate Summary
Table 95. C.B. Fleet Company Opioid Induced Constipation Drugs Product Offerings
Table 96. C.B. Fleet Company Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 97. Sucampo Pharmaceuticals Corporate Summary
Table 98. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product Offerings
Table 99. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 100. Opioid Induced Constipation Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2019-2021 (K Pcs)
Table 101. Global Opioid Induced Constipation Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 102. Global Opioid Induced Constipation Drugs Production by Region, 2016-2021 (K Pcs)
Table 103. Global Opioid Induced Constipation Drugs Production by Region, 2022-2027 (K Pcs)
Table 104. Opioid Induced Constipation Drugs Market Opportunities & Trends in Global Market
Table 105. Opioid Induced Constipation Drugs Market Drivers in Global Market
Table 106. Opioid Induced Constipation Drugs Market Restraints in Global Market
Table 107. Opioid Induced Constipation Drugs Raw Materials
Table 108. Opioid Induced Constipation Drugs Raw Materials Suppliers in Global Market
Table 109. Typical Opioid Induced Constipation Drugs Downstream
Table 110. Opioid Induced Constipation Drugs Downstream Clients in Global Market
Table 111. Opioid Induced Constipation Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Opioid Induced Constipation Drugs Segment by Type
Figure 2. Opioid Induced Constipation Drugs Segment by Application
Figure 3. Global Opioid Induced Constipation Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Opioid Induced Constipation Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Opioid Induced Constipation Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Opioid Induced Constipation Drugs Sales in Global Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Opioid Induced Constipation Drugs Revenue in 2020
Figure 9. By Type - Global Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
Figure 10. By Type - Global Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
Figure 11. By Type - Global Opioid Induced Constipation Drugs Price (USD/Pcs), 2016-2027
Figure 12. By Application - Global Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
Figure 13. By Application - Global Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
Figure 14. By Application - Global Opioid Induced Constipation Drugs Price (USD/Pcs), 2016-2027
Figure 15. By Region - Global Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
Figure 16. By Region - Global Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
Figure 17. By Country - North America Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
Figure 18. By Country - North America Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
Figure 19. US Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
Figure 24. Germany Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. France Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
Figure 33. China Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. India Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
Figure 39. By Country - South America Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
Figure 40. Brazil Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Opioid Induced Constipation Drugs Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share, 2016-2027
Figure 44. Turkey Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Opioid Induced Constipation Drugs Revenue, (US$, Mn), 2016-2027
Figure 48. Global Opioid Induced Constipation Drugs Production Capacity (K Pcs), 2016-2027
Figure 49. The Percentage of Production Opioid Induced Constipation Drugs by Region, 2020 VS 2027
Figure 50. Opioid Induced Constipation Drugs Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs